Australia's most trusted
source of pharma news
Thursday, 06 February 2025
Posted 5 February 2024 AM
Most pharmas saw their market cap slide in 2024 thanks to challenging headwinds from shifting policies and regulatory concerns, but a few success stories counterbalanced that.
Analysis of the market capitalisation of the top 20 pharmaceutical companies found that over two-thirds of them saw their market cap fall over 2024.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.